Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Various cells and organs in the human body originate from a small group of primitive cells called stem cells. Human cancer cells were also recently found to arise from a…

Continue ReadingCombinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells

RNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Advancing our understanding of stem cell biology often relies on answers to the following types of questions: What are the differences in gene expression between a stem cell and the…

Continue ReadingRNA Analysis by Biosynthetic Tagging (RABT): a tool for the identification of cell type-specific RNAs

Derivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Cancer is the leading cause of death for people younger than 85. High cancer mortality rates related to resistance to therapy and malignant progression underscore the need for more sensitive…

Continue ReadingDerivation and Characterization of Myeloproliferative Disorder Stem Cells from Human ES Cells

Stem Cells in Lung Cancer

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Lung cancer is the most deadly cancer worldwide and accounts for more deaths than prostate cancer, breast cancer and colon cancer combined. Non small cell lung cancer (NSCLC) accounts for…

Continue ReadingStem Cells in Lung Cancer

Derivation and Characterization of Cancer Stem Cells from Human ES Cells

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Cancer is the leading cause of death for people younger than 85 (1). High cancer mortality rates underscore the need for more sensitive diagnostic techniques as well as therapies that…

Continue ReadingDerivation and Characterization of Cancer Stem Cells from Human ES Cells

Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Acute myeloid leukemia (AML) is a cancer of the blood and bone marrow that is rapidly fatal within months if untreated. Even with aggressive treatment, including chemotherapy and bone marrow…

Continue ReadingDevelopment of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells

Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Cancer is a major cause of human death worldwide. The vast majority of cancer patients suffer from solid tumors whose growth destroys vital organs. We propose to develop novel therapeutic…

Continue ReadingTherapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors

Development of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

  • Post author:
  • Post published:June 1, 2026
  • Post category:

Leukemias are cancers of the blood forming cells that afflict both children and adults. Many drugs have been developed to treat leukemias and related diseases. These drugs are often effective…

Continue ReadingDevelopment of Highly Active Anti-Leukemia Stem Cell Therapy (HALT)

Investigating the SGF29/SAGA complex in regulation of normal and cancer stem cells

  • Post author:
  • Post published:May 31, 2026
  • Post category:

Research Objective This study will address gaps in our understanding of how normal and cancer stem cells differ in their epigenetic states, helping develop new cancer-stem-cell-targeting therapis. Impact The long-term…

Continue ReadingInvestigating the SGF29/SAGA complex in regulation of normal and cancer stem cells

Therapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling

  • Post author:
  • Post published:May 31, 2026
  • Post category:

Research Objective This DISC2 tests a strategy to target survival and self-renewal in glioma stem cells (GSC), and will identify a therapeutic candidate for safety, dosing and efficacy testing. Impact…

Continue ReadingTherapeutic targeting of Glioblastoma Stem Cell survival and self-renewal signaling
  • 1
  • 2
  • 3
  • 4
  • 5
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us